[go: up one dir, main page]

IT201700002235A1 - Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere - Google Patents

Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere

Info

Publication number
IT201700002235A1
IT201700002235A1 IT102017000002235A IT201700002235A IT201700002235A1 IT 201700002235 A1 IT201700002235 A1 IT 201700002235A1 IT 102017000002235 A IT102017000002235 A IT 102017000002235A IT 201700002235 A IT201700002235 A IT 201700002235A IT 201700002235 A1 IT201700002235 A1 IT 201700002235A1
Authority
IT
Italy
Prior art keywords
diabetes
treatment
composition
general
oral administration
Prior art date
Application number
IT102017000002235A
Other languages
English (en)
Inventor
Tullio Romussi
Original Assignee
Arche Frama Srls
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arche Frama Srls filed Critical Arche Frama Srls
Priority to IT102017000002235A priority Critical patent/IT201700002235A1/it
Publication of IT201700002235A1 publication Critical patent/IT201700002235A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IT102017000002235A 2017-06-07 2017-06-07 Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere IT201700002235A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000002235A IT201700002235A1 (it) 2017-06-07 2017-06-07 Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000002235A IT201700002235A1 (it) 2017-06-07 2017-06-07 Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere

Publications (1)

Publication Number Publication Date
IT201700002235A1 true IT201700002235A1 (it) 2018-12-07

Family

ID=60293988

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000002235A IT201700002235A1 (it) 2017-06-07 2017-06-07 Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere

Country Status (1)

Country Link
IT (1) IT201700002235A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025349A1 (en) * 2000-05-02 2002-02-28 Brindavanam Narasimha Baba Novel herbal composition for diabetes patients and a process for producing the same
US20160296577A1 (en) * 2013-10-28 2016-10-13 Piramal Enterprises Limited Herbal composition, process for its preparation and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025349A1 (en) * 2000-05-02 2002-02-28 Brindavanam Narasimha Baba Novel herbal composition for diabetes patients and a process for producing the same
US20160296577A1 (en) * 2013-10-28 2016-10-13 Piramal Enterprises Limited Herbal composition, process for its preparation and use thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DHANABAL S P ET AL: "Hypoglycaemic activity of Pterocarpusmarsupium Roxb", PHYTOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, vol. 20, no. 1, 1 January 2006 (2006-01-01), pages 4 - 8, XP009503305, ISSN: 0951-418X, [retrieved on 20060105], DOI: 10.1002/PTR.1819 *
GUPTA R ET AL: "Protective role of Pterocarpus marsupium in diabetes-induced hyperlipidemic condition", JOURNAL OF COMPLEMENTARY AND INTEGRATIVE MEDICINE, BERKELEY ELECTRONIC PRESS, UK, vol. 6, no. 1, 1 January 2009 (2009-01-01), XP009503312, ISSN: 1553-3840 *
JUN LIU ET AL: "Chromium, Selenium, and Zinc Multimineral Enriched Yeast Supplementation Ameliorates Diabetes Symptom in Streptozocin-Induced Mice", BIOLOGICAL TRACE ELEMENT RESEARCH, HUMANA PRESS INC, NEW YORK, vol. 146, no. 2, 12 November 2011 (2011-11-12), pages 236 - 245, XP035033321, ISSN: 1559-0720, DOI: 10.1007/S12011-011-9248-X *
QIXUAN CHEN ET AL: "Nutrient Metabolism Bitter Melon (Momordica charantia) Reduces Adiposity, Lowers Serum Insulin and Normalizes Glucose Tolerance in Rats Fed a High Fat Diet 1", 1 January 2003 (2003-01-01), XP055358559, Retrieved from the Internet <URL:http://jn.nutrition.org/content/133/4/1088.full.pdf#page=1&view=FitH> [retrieved on 20170324] *

Similar Documents

Publication Publication Date Title
DOP2018000297A (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo
MX2015009104A (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
BR112018004532A2 (pt) uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
EA202191513A1 (ru) Снижение вязкости фармацевтических составов
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
DK3098224T3 (da) Pyranochromenyl-phenolderivat og farmaceutisk sammensætning til behandling af metabolisk syndrom eller inflammationssygdom
EP3597208A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING ATPIF1 FOR THE TREATMENT OF DIABETES
CL2016001746A1 (es) Derivados de hidroxi formamida y sus usos
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
MX2017009294A (es) Tratamiento de pacientes pediatricos con diabetes mellitus de tipo 2 con lixisenatida.
BR112017021190A2 (pt) composição farmacêutica e o uso da mesma
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
MX2016011025A (es) Composiciones de grapiprant y metodos para usar las mismas.
ECSP16086232A (es) (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
MD20180049A2 (ro) Compoziţie farmaceutică
CL2015003211A1 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio.
DK3867244T3 (da) 4-pyrazin-2-ylmethylmorfolinderivater og anvendelse deraf som lægemiddel
IT201700002235A1 (it) Composizione per somministrazione orale utile nel trattamento del diabete e delle sindrome metaboliche in genere